These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24969574)

  • 1. Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study.
    Perreault L; Temprosa M; Mather KJ; Horton E; Kitabchi A; Larkin M; Montez MG; Thayer D; Orchard TJ; Hamman RF; Goldberg RB;
    Diabetes Care; 2014 Sep; 37(9):2622-31. PubMed ID: 24969574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
    Perreault L; Pan Q; Mather KJ; Watson KE; Hamman RF; Kahn SE;
    Lancet; 2012 Jun; 379(9833):2243-51. PubMed ID: 22683134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS).
    Perreault L; Pan Q; Schroeder EB; Kalyani RR; Bray GA; Dagogo-Jack S; White NH; Goldberg RB; Kahn SE; Knowler WC; Mathioudakis N; Dabelea D;
    Diabetes Care; 2019 Sep; 42(9):1809-1815. PubMed ID: 31320445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program.
    Pratte KA; Johnson A; Beals J; Bullock A; Manson SM; Jiang L;
    Diabetes Care; 2019 Jul; 42(7):1209-1216. PubMed ID: 31177184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes.
    Wang T; Lu J; Su Q; Chen Y; Bi Y; Mu Y; Chen L; Hu R; Tang X; Yu X; Li M; Xu M; Xu Y; Zhao Z; Yan L; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Shi L; Ning G; Zhao J; Wang W;
    JAMA Cardiol; 2019 Sep; 4(9):874-883. PubMed ID: 31365039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
    Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
    Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, Design, and Baseline Characteristics of Beijing Prediabetes Reversion Program: A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Lifestyle Intervention and/or Pioglitazone in Reversion to Normal Glucose Tolerance in Prediabetes.
    Luo Y; Paul SK; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Wang H
    J Diabetes Res; 2017; 2017():7602408. PubMed ID: 28168204
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.
    Vistisen D; Kivimäki M; Perreault L; Hulman A; Witte DR; Brunner EJ; Tabák A; Jørgensen ME; Færch K
    Diabetologia; 2019 Aug; 62(8):1385-1390. PubMed ID: 31123789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Purified Anthocyanins in Improving Cardiometabolic Risk Factors in Chinese Men and Women with Prediabetes or Early Untreated Diabetes-A Randomized Controlled Trial.
    Yang L; Ling W; Yang Y; Chen Y; Tian Z; Du Z; Chen J; Xie Y; Liu Z; Yang L
    Nutrients; 2017 Oct; 9(10):. PubMed ID: 28994705
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
    Sandforth A; von Schwartzenberg RJ; Arreola EV; Hanson RL; Sancar G; Katzenstein S; Lange K; Preißl H; Dreher SI; Weigert C; Wagner R; Kantartzis K; Machann J; Schick F; Lehmann R; Peter A; Katsouli N; Ntziachristos V; Dannecker C; Fritsche L; Perakakis N; Heni M; Nawroth PP; Kopf S; Pfeiffer AFH; Kabisch S; Stumvoll M; Schwarz PEH; Hauner H; Lechner A; Seissler J; Yurchenko I; Icks A; Solimena M; Häring HU; Szendroedi J; Schürmann A; de Angelis MH; Blüher M; Roden M; Bornstein SR; Stefan N; Fritsche A; Birkenfeld AL
    Lancet Diabetes Endocrinol; 2023 Nov; 11(11):798-810. PubMed ID: 37769677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
    Krum H; McMurray JJ; Horton E; Gerlock T; Holzhauer B; Zuurman L; Haffner SM; Bethel MA; Holman RR; Califf RM
    Cardiovasc Ther; 2010 Apr; 28(2):124-32. PubMed ID: 20184589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a Metabolic Syndrome Severity
    DeBoer MD; Filipp SL; Gurka MJ
    Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Should Not Be Used to Treat Prediabetes.
    Davidson MB
    Diabetes Care; 2020 Sep; 43(9):1983-1987. PubMed ID: 32936780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.
    Perreault L; Kahn SE; Christophi CA; Knowler WC; Hamman RF;
    Diabetes Care; 2009 Sep; 32(9):1583-8. PubMed ID: 19587364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediterranean Diet and 10-year (2002-2012) Incidence of Diabetes and Cardiovascular Disease in Participants with Prediabetes: The ATTICA study.
    Filippatos TD; Panagiotakos DB; Georgousopoulou EN; Pitaraki E; Kouli GM; Chrysohoou C; Tousoulis D; Stefanadis C; Pitsavos C;
    Rev Diabet Stud; 2016; 13(4):226-235. PubMed ID: 28278309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
    Roman G; Hancu N
    Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
    Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study.
    Desouza C; Chatterjee R; Vickery EM; Nelson J; Johnson KC; Kashyap SR; Lewis MR; Margolis K; Pratley R; Rasouli N; Sheehan PR; Pittas AG;
    J Diabetes Complications; 2022 Aug; 36(8):108230. PubMed ID: 35753926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Controlled Clinical Trial of Lifestyle Intervention and Pioglitazone for Normalization of Glucose Status in Chinese with Prediabetes.
    Luo Y; Wang H; Zhou X; Chang C; Chen W; Guo X; Yang J; Ji L; Paul SK
    J Diabetes Res; 2022; 2022():2971382. PubMed ID: 35036447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.